Step closer to tackling drug resistant parasites in Brazil

Positive Clinical Results for Alzheimer’s Amyloid-Clearing Drug – Lecanemab Poised for FDA Approval

Integrated platform promises to accelerate drug discovery process

Heralded Alzheimer’s drug works — but safety concerns loom